MiR-129-5p levels were decreased in mouse depression models. حسب Qiaozhen Qin (13159201)

"…The Y-axis represents the fold change, while the X-axis indicates the significance of differential expression. …"

IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1. حسب Iratxe Zuazo-Gaztelu (21071939)

Settling time for changes in the median of the Folded Normal distribution. حسب Ariel Burman (20329776)

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

"…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …"

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

"…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …"

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

"…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …"

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

"…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …"

IRE1 depletion increases chromosome instability. حسب Iratxe Zuazo-Gaztelu (21071939)

IRE1 depletion increases chromosome instability. حسب Iratxe Zuazo-Gaztelu (21071939)

RNA analysis reveals a ~6-fold reduced coverage of exon 26 in the murine <i>Tg</i> gene. حسب Wendy J. Bailey (14926392)

a) FB image processing featuring (1) FB map, (2) TWOMBLI mask, (3) FB-mask multiplied image, and (4) Ridge detection selection of contours. b) TWOMBLI Output Descriptions. (1) Area... حسب Zoë Dinkel (21402766)

Minimal dataset. حسب Jennifer M. Kwan (3350321)

"…Dual ICI therapy was also associated with a 2.0-fold increased risk of myo/pericarditis (<i>P</i> = 0.045), with myo/pericarditis being associated with a 2.9-fold increased risk of mortality (<i>P</i><0.001). …"

Lipidomic analysis of epidermis using LC-IMS-CID-MS reveals major changes in CKO// epidermis. حسب Kevin J. Mills (9270966)

"…(E) Dendrogram showing all 247 significantly changed lipids in CKO epidermis. …"

The spatial pattern of dengue including hotspot and coldspot in Bangladesh in 2019–2023. حسب Kamal Hossain (331680)

The spatial distribution of dengue incidence rate per million by month across districts of Bangladesh in 2023. حسب Kamal Hossain (331680)

The spatial distribution of dengue incidence rate per million by month across districts of Bangladesh in 2022. حسب Kamal Hossain (331680)

The spatial distribution of districtwide dengue cases and dengue incidence rate (DIR) per million in Bangladesh in 2019–2023. حسب Kamal Hossain (331680)

Flowchart of Methodology. حسب Kamal Hossain (331680)

"…The case fatality rate also demonstrated a steadily rise, reaching 0.5% in 2023 with 321,179 cases (a five-fold increase compare to 2022). Interestingly, the proportion of cases in Dhaka city decreased from 51% in 2019 to 34% in 2023. …"

<i>N. parisii</i> induces global changes to <i>C. elegans</i> lipidome. حسب Hala Tamim El Jarkass (16625309)

IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors. حسب Iratxe Zuazo-Gaztelu (21071939)